Entero Therapeutics, Inc. (ENTO)

Entero Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3	3	5	18	29	27
Market Cap Growth	-	-44.13%	-71.82%	-38.96%	8.45%	32.70%
Enterprise Value	7	-0	5	11	24	29
PE Ratio	-1.38	-0.18	-0.34	-0.21	-0.71	-1.79
PB Ratio	0.22	0.79	1.85	-2.30	-11.17	5.89
P/FCF Ratio	-0.67	-0.23	-0.23	-0.56	-2.65	-1.93
P/OCF Ratio	-0.67	-0.23	-0.23	-0.56	-2.63	-1.94
EV/EBITDA Ratio	-0.59	0.01	-0.31	-0.19	-0.91	-2.08
EV/EBIT Ratio	-0.59	0.01	-0.31	-0.18	-0.89	-1.93
EV/FCF Ratio	-0.93	0.01	-0.20	-0.33	-2.15	-2.03
Debt / Equity Ratio	0.43	0.23	0.32	-0.13	-0.21	0.33
Debt / EBITDA Ratio	-0.33	-0.05	-0.06	-0.02	-0.02	-0.11
Debt / FCF Ratio	-0.53	-0.07	-0.04	-0.03	-0.05	-0.11
Quick Ratio	0.56	1.20	0.60	0.67	0.43	0.67
Current Ratio	1.21	1.58	1.37	0.77	0.51	0.80
Interest Coverage	-262.77	-702.16	-920.32	-5209.31	-4.59	-33.98
Return on Equity (ROE)	-107.60%	-614.80%	260.80%	-5086.10%	-1221.30%	-450.40%
Return on Assets (ROA)	-23.80%	-284.10%	-262.30%	-604.00%	-373.50%	-164.50%
Return on Capital (ROIC)	-90.36%	-356.02%	-349.66%	869.61%	1265.76%	-240.18%
Earnings Yield	-184.37%	-568.01%	-295.07%	-469.39%	-141.47%	-55.80%
FCF Yield	-379.97%	-436.61%	-440.32%	-179.71%	-37.74%	-51.68%
Buyback Yield / Dilution	-12625.67%	-836.57%	-1589.98%	-213.88%	-26.78%	-45.11%
Total Shareholder Return	-12625.67%	-836.57%	-1589.98%	-213.88%	-26.78%	-45.11%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).